L. Grimaldi

May baseline JCV status influence the MS clinical evolution during Natalizumab treatment? Evidence from a multicenter-2 years-prospective study

E. D’Amico, F. Patti, A. Signori, 2017, Multiple Sclerosis and Demyelinating Disorders.

Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases

M. Filippi, C. Pozzilli, M. Rocca, 2013, Multiple sclerosis.

Cytokine Genes in Multiple Sclerosis

F. Sciacca, L. Grimaldi, 1999 .

Analysis of an IFN-gamma gene (IFNG) polymorphism in multiple sclerosis in Europe: effect of population structure on association with disease.

A. Goris, T. Olsson, G. Opdenakker, 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

HLA-A*01 is Associated with Late Onset of Alzheimer's Disease in Italian Patients

M. Franceschi, C. Tinelli, F. Guerini, 2009, International journal of immunopathology and pharmacology.

Lack of association between the interferon regulatory factor-1 (IRF1) locus at 5q31.1 and multiple sclerosis in Germany, Northern Italy, Sardinia and Sweden

T. Olsson, G. Opdenakker, K. Vandenbroeck, 2000, Genes and Immunity.

Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease

M. Tsolaki, R. Nitsch, J. Streffer, 2003, Molecular Psychiatry.

The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing–remitting multiple sclerosis

M. Filippi, E. Scarpini, G. Edan, 2009, Multiple sclerosis.

An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients

G. Comi, M. Filippi, G. Comi, 2003, Multiple sclerosis.

Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

G. Bernardi, M. Trojano, L. Grimaldi, 1994, Journal of neurology, neurosurgery, and psychiatry.